This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Adult fibroblast
Blood
Bone marrow CD34+ cells
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Cerebrospinal fluid
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mast cell (HMC-1)
Pancreatic cancer cells (AsPC1, BxPC3, Capan1, Capan2, MiaPaca2, Panc1, Pt45P1, A818, Colo357, HD3577)
Plasma
Saliva
Serum
By sample status
2 years old
24 hr culture
70 years old
72 hr culture
Acute myeloid leukemia
Cisplatin-resistant
Extremely severe hand, foot, and mouth disease
Healthy_timepoint1
Healthy_timepoint2
Low density
Mild hand, foot, and mouth disease
Multiple sclerosis
Normal
Normal_Agilent
Normal_Exiqon
Omeprazole-treated
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Transplant islets into mouse xenotransplantation
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-3656
MIMAT0018076
0.0e+0
2.7e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
6.4e-2
Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs.
PLoS One. 2014 Nov 24;9(11):e113116. doi: 10.1371/journal.pone.0113116. eCollection 2014.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
9.1e-2
Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs.
PLoS One. 2014 Nov 24;9(11):e113116. doi: 10.1371/journal.pone.0113116. eCollection 2014.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.2e-15
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
8.2e-15
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
5.1e-10
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.8e-10
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
8.8e-5
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.2e-12
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
5.3e-11
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.4e-5
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.4e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.7e-3
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.2e-2
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
3.7e-15
2.6e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
1.3e-10
2.3e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.5e-5
Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.5e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.5e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.4e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.5e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
2.5e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
5.4e-2
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
6.7e-2
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
8.9e-2
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.0e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
8.0e-3
8.0e-3
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
9.4e-3
9.4e-3
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
1.6e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
0.0e+0
6.2e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
6.9e-4
6.9e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
Not available
43
/
0
/
43
hsa-miR-3656
MIMAT0018076
8.3e-4
8.3e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
Not available
43
/
0
/
43
<
[2]